Dear Colleagues,
We are pleased to remind you of our 2nd webinar series on the WHO Essential Medicines List 2025 Update, Polypharmacy and Implications for Multimorbidity Care in Africa jointly hosted by the Guidelines International Network (GIN) multimorbidity Working group, WHO and the West African Institute for Applied Health Research -WAFERs.
Key objectives are to:
* Understand the impact of WHO EML 2025 update on NCDs and multimorbidity care in Africa
* Understand how to improve development, and use of evidence to improve high-value care, address polypharmacy and multimorbidity with the aid of WHO design principles and tools.
* Examine opportunities for embedding evidence-informed multimorbidity care and approaches within own country health services especially in high burden, low resource contexts (e.g. Africa)
* Connect with peers to exchange lessons and best practices.
�� Dates: 12th November 2025
�� Time: 15.00 CET
�� Platform: Zoom
To register to attend, and gain access to the Webinar, please follow this link: https://shorturl.at/FY5kv
Also see the attached flyer for further information, speakers and panellists [HIFA mod note: HIFA is plain text and deoes not carry attachments, NPW]. Feel free to forward to others to whom this may be of interest. We hope to see you there.
Kind Regards,
Yemi
Opeyemi Babatunde Senior Lecturer: Evidence Synthesis and Applied Health Research
School of Medicine, Primary Care Centre Versus Arthritis | Keele University, Keele, Staffordshire, UK ST5 5BG
Hon. Professor & Visiting Scholar: Global Health Research and Knowledge Mobilisation - University of Ibadan.
Tel: 01782 733927 | Email: o.babatunde@keele.ac.uk | www.keele.ac.uk<https://www.keele.ac.uk/>
I am a Guest Editor for BMC Musculoskeletal Disorders for this special highlight and call for papers: Musculoskeletal disorders management: https://bit.ly/3DpAFMH
HIFA profile: Opeyemi Babatunde is a lecturer at Keele University in the UK. o.babatunde AT keele.ac.uk